v3.25.4
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance – September 30, 2024 at Jul. 22, 2024
Beginning balance, shares at Jul. 22, 2024 [1]      
Founder shares issued to the Sponsor [1] $ 290 24,710 25,000
Founder shares issued to the Sponsor, shares [1] 2,898,000      
Net loss (12,089) (12,089)
Balance – December 31, 2024 at Sep. 30, 2024 $ 290 24,710 (12,089) 12,911
Ending balance, shares at Sep. 30, 2024 [1] 2,898,000      
Net loss (3,840) (3,840)
Balance – December 31, 2024 at Dec. 31, 2024 $ 290 24,710 (15,929) 9,071
Ending balance, shares at Dec. 31, 2024 [1] 2,898,000      
Balance – September 30, 2024 at Mar. 31, 2025 $ 290 24,710 (16,018) 8,982
Beginning balance, shares at Mar. 31, 2025 [1] 2,898,000      
Net loss (15,459) (15,459)
Balance – December 31, 2024 at Jun. 30, 2025 $ 290 24,710 (31,477) (6,477)
Ending balance, shares at Jun. 30, 2025 [1] 2,898,000      
Issuance of Private Placement Units $ 23 2,286,477 2,286,500
Issuance of Private Placement Units, shares [1] 228,650      
Issuance of Public Rights net of issuance costs of $102,558 1,801,841 1,801,841
Remeasurement of carrying value to redemption value (6,763,887) (6,763,887)
Accretion of additional paid-in capital to accumulated deficit 2,650,859 (2,650,859)
Net loss (90,319) (90,319)
Balance – December 31, 2024 at Sep. 30, 2025 $ 313 (2,772,655) (2,772,342)
Ending balance, shares at Sep. 30, 2025 [1] 3,126,650      
Remeasurement of carrying value to redemption value and accretion to addition paid-in capital to accumulated deficit (803,606) (803,606)
Net loss 521,600 521,600
Balance – December 31, 2024 at Dec. 31, 2025 $ 313 $ (3,054,661) $ (3,054,348)
Ending balance, shares at Dec. 31, 2025 [1] 3,126,650      
[1] Ordinary shares have been retroactively restated to reflect the first amendment to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares from 2,415,000 to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).